Technology
Autonomous AI-Driven Retinal Disease Screening Platform for Primary Care
Executive Summary Lumière.ai is a fully autonomous advanced AI-powered screening platform designed to detect major sight threatening retinal diseases including glaucoma, diabetic retinopathy (DR), age-related macular degeneration (AMD), and retinal vein occlusion (RVO) using portable fundus cameras and deep learning. Deployed in primary care settings, Lumière.ai enables early, accessible, and cost-effective detection without specialist involvement at the point of care.
Problem Statement Retinal diseases are among the leading causes of preventable blindness globally. Yet, early-stage conditions are often undetected due to the lack of screening infrastructure and limited access to ophthalmic specialists. Current workflows are expensive and inefficient, leading to late diagnoses and poorer and preventable outcomes.
Solution Overview Lumière.ai integrates a non-mydriatic portable fundus camera with a high-performance AI engine to autonomously manage patient interaction and analyze retinal images. The system determines in real time whether a patient requires referral to a specialist. Lumière.ai empowers primary care providers and community clinics to perform large-scale screening programs efficiently and autonomously.
Market Opportunity Targeting a global ophthalmic diagnostics market expected to exceed $2.5B, Lumière.ai is positioned to serve aging populations and diabetes-prevalent regions. The platform addresses public health priorities by reducing the burden of late-stage vision loss and healthcare costs through scalable, preventive screening.
Competitive Edge
• Multi-disease Detection: Identifies glaucoma, DR, AMD, and RVO from a single retinal image.
• Fully Autonomous Workflow: Manages patient interaction and triage without human intervention.
• Proven Accuracy: Validated by peer-reviewed studies and powered by advanced deep learning algorithms.
• Portable and Cost-Effective: Non-invasive, low-cost setup requiring no pupil dilation.
• Seamless Integration: Designed for primary care and health maintenance organization (HMO) workflows, enabling rapid adoption.
Advantages
- Equity in Access to Vision Care:
By operating autonomously in primary care settings, Lumière.ai bridges the diagnostic gap in underserved or rural areas where ophthalmologists are scarce, supporting equitable access to early eye disease detection. - Real-Time Decision Support:
The platform provides immediate clinical recommendations based on image analysis, allowing healthcare providers to make timely decisions and initiate referral pathways during the same visit — improving patient adherence and continuity of care.
Applications
- Ophthalmology
Business Development Contacts